| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
3,089 |
3,006 |
$313K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
1,138 |
1,138 |
$162K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
961 |
937 |
$48K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
373 |
368 |
$28K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
269 |
269 |
$26K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
183 |
182 |
$15K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
440 |
436 |
$15K |
| 87428 |
|
347 |
344 |
$10K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
221 |
221 |
$6K |
| 99051 |
|
768 |
761 |
$5K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
335 |
334 |
$5K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
73 |
73 |
$3K |
| 87430 |
|
130 |
128 |
$2K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
24 |
24 |
$2K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
18 |
18 |
$877.32 |